WallStreetZenWallStreetZen

NASDAQ: ITRM
Iterum Therapeutics PLC Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ITRM stock forecasts and price targets.

Forecast return on equity

Is ITRM forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%

Forecast return on assets

Is ITRM forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

ITRM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ITRM$0.76N/AN/A
CMMB$0.89$7.00+686.52%Buy
IMNN$1.04$12.00+1,053.85%Buy
ARAV$0.13$7.42+5,518.94%Buy
GTBP$0.25$3.50+1,305.62%Buy

Iterum Therapeutics Stock Forecast FAQ

What is ITRM's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ITRM) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.

What is ITRM's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ITRM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.